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Model good parenting skills, educate 
parents about basic behavioral tools,
provide referral as resources allow
It can be challenging to distinguish opposi-
tional defiant behaviors from variations of
normal development as adolescents try to
become “independent” from their parents.
However, adolescents may engage in many
dangerous risk-taking behaviors during this
period, so timely diagnosis and interventions
are important. Affected adolescents often
have a difficult home life, with parents who
may have very poor social support and 
coping skills. Typically, such parents must be
convinced that the oppositional and defiant
behaviors are a family problem requiring a
family solution with no quick fix. Significant
financial barriers to counseling and other
resources are also common in many of
these families. At a minimum, the family 
doctor can model good parenting skills in
the exam room, educate parents about basic
behavioral tools to use when interacting 
with their adolescents, and provide referral
as resources allow.
Elizabeth A. Rulon, MD
Family Medicine Residency of Idaho, Boise
Psychological interventions for the family—
such as parenting skills training and 
behavioral therapy for the child, the parents,
or the whole family—reduce conflict 
behaviors in adolescents with oppositional
defiant disorder (ODD) (strength of 
recommendation [SOR]: C, based on 
extrapolation from systematic reviews of
younger children with ODD and adolescents
with conduct disorder).
ODD most commonly does not occur as a
solitary diagnosis. When ODD is associated
with attention deficit/hyperactivity disorder
(ADHD) or other medication-responsive
comorbid conditions, medical treatment
reduces overall symptoms (SOR: B, based
on a meta-analysis of adolescent and
younger children with both ODD and ADHD).
z Evidence summary
No studies specifically evaluate effective
treatments for ODD (distinguished by
chronic argumentativeness and refusal to
comply with adult requests) for adolescent
patients. However, there are treatment
studies of younger children with ODD and
studies of adolescents with the more 
disruptive behavior problem of conduct
disorder (distinguished by a persistent pat-
tern of violating other’s rights, aggression,
and illegal acts). 
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A Clinical Inquiry summarized 8 
well-done systematic reviews of ODD
treatments of preadolescent children and
found improved behavior with parenting
interventions and behavioral therapy.1
Each of the systematic reviews assessed
multiple randomized controlled trials
(RCTs) using a variety of parenting and
behavioral therapy interventions. The
most rigorous systematic review (which
included 16 RCTs), compared group-
based parenting skills training with
untreated wait-list controls and found
decreased aggression, noncompliance, and
temper tantrums by children aged 3 to 10
years (total number of subjects not given)
by an average effect size of 0.6 to 2.9.
(Effect size is the difference between the
means of the experimental and control
groups expressed in standard deviations.
An effect size of 0.2 is considered small,
0.5 is medium, and 0.8 is moderate to
large.) Behavioral therapy (cognitive-
behavioral therapy, social problem-solving
skills training, parent management train-
ing), comprising 12 to 25 sessions with
either the child alone or with teachers or
parents, decreased disruptive or aggressive
behaviors by 20% to 30%.
A 2-year case-control study2 of 158
self-referred families with young adoles-
cents (11 to 14 years old) without a formal
ODD diagnosis but with reported problem
behaviors (defined as smoking, negative
engagement in family problem solving,
and parental ratings of unpleasant events)
found significant improvements (P<.01)
with parent-only, teen-only, and parent-
teen behavioral interventions for negative
engagement behaviors (average of 30%
reduction in scores), and with parent and
teen interventions for unpleasant events
(average of 9% reduction in scores).
Interventions comprised 12 weekly 90-
minute sessions, with the parent-only
group targeting family management 
practices and communication skills, the
teen-only group targeting adolescent self-
regulation and pro-social behavior, and the
parent-teen group following a structured
curriculum.
A meta-analysis3 of 8 RCTs (with a
total of 749 children) of various behavioral
treatments for conduct disorder and juve-
nile delinquency among children aged 10
to 17 years found significant reductions in
rearrest rates (relative risk [RR]=0.66;
95% confidence interval [CI], 0.44–0.98;
number needed to treat [NNT] to prevent
1 rearrest=3.7) and time spent in institu-
tions (mean difference, 51 days) with 
family and parenting interventions (com-
prising 1 to 6 months of individual and
group parenting training, short and long-
term family therapy, and individual and
group adolescent interventions).
ODD comorbid 
with other psychiatric conditions
Approximately half to two-thirds of 
adolescents with ODD also have ADHD.4
A meta-analysis5 evaluated 28 studies of
stimulant medication (methylphenidate,
amphetamine, or pemoline) for children
with comorbid ADHD and ODD. A total
of 683 patients aged 8 to 18 years were
included. Stimulants reduced aggression-
related behaviors in these children by an
effect size of 0.84 for overt aggression and
0.69 for covert aggression. Stimulants typ-
ically reduce aggressive behaviors by simi-
lar effect sizes when prescribed for children
with ADD alone. The study groups did not
separate children with ADHD and ODD
from those with ADHD and conduct dis-
order; they also grouped adolescents
together with younger children.
An RCT6 of different doses of atomox-
etine (Strattera) treatment vs placebo for
children ages 8 to 18 (mean age=11) with
ADHD alone (N=178) and children with
both ADHD and ODD (N=115) found sig-
nificant effect sizes for atomoxetine in
both groups. Two dosages of atomoxetine
(1.2 and 1.8 mg/kg/d) produced equivalent
effect sizes in the ADHD-only group (0.55
and 0.56); however, the higher dosage had
a greater effect size (0.49 vs 0.69) in the
group with ODD comorbid with ADHD.  
A double-blind crossover RCT7 evalu-
ated divalproex (Depakote) vs placebo for
20 children (aged 10 to 18 years) with
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explosive temper and mood lability who
also met DSM-IV criteria for either ODD
or conduct disorder. Patients with signifi-
cant medical problems, such as bipolar dis-
order, major depression, or mental retarda-
tion, were excluded. Divalproex signifi-
cantly (P=.003) reduced aggressive behav-
iors and anger-hostility items by approxi-
mately 33% as reported by child, parent,
school, and clinician on 2 standardized
scales.
Experts say antidepressant medica-
tions may be helpful in treating children
with conduct disorder and comorbid
major depression.8
Recommendations by others
An international consensus statement on
ADHD and disruptive behavior disorders
(comprising ODD, conduct disorder, and
disruptive behavior not otherwise speci-
fied) says that psychopharmacologic treat-
ment would not be appropriate for cases of
ODD in the absence of psychiatric comor-
bidity, unless severe aggression or destruc-
tive behavior persisted despite attempts at
psychosocial interventions of established
efficacy.4 
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